| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.52 | 0.002 |